Skip to main content
Third-party tested
Purity documentation available
Research supply chain
Compliance notice included
Cagrilintide 10 mg research peptide vial, Validated Peptides
99%+ Purity

Cagrilintide Peptide for Sale

Cagrilintide, developed under the code AM833, is a synthetic analog of amylin, the hormone the pancreas co-secretes with insulin after a meal. A fatty-acid chain attached through a glutamate spacer lets it bind albumin, which is why its measured half-life runs to roughly 159 to 195 hours where native amylin clears in minutes. Receptor pharmacology work across 25 endpoints characterized it as a non-selective agonist of the calcitonin receptor family, meaning it activates the amylin receptors built from the calcitonin receptor plus receptor activity-modifying proteins as well as the calcitonin receptor on its own, with a binding and regulation profile distinct from selective analogs such as pramlintide. Published trials have measured body weight, glycemic parameters and gastrointestinal tolerability, both alone and co-administered with GLP-1S. Those data come from the sponsor's investigational drug product, not from research material.

1
$89.99
We accept

Cagrilintide Certificate of Analysis

Third Party TestedLab Verifiable
Lab Verified3rd Party
99.73%
Purity
Passed full QC panel
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Purity (HPLC)99.73%
Net Peptide Content10.62mg
Identity (HPLC)Confirmed
Heavy Metals (ICP-MS)Pass
Microbial screen (PCR)No Growth
Endotoxin (USP <85>)NMT 0.05 EU/mL
Independent Lab Report
Lab Verified3rd Party
Pass
Identity
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Identity (HPLC)Confirmed
Independent Lab Report
Lab Verified3rd Party
10.62mg
Net Peptide Content
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Independent Lab Report
Lab Verified3rd Party
Pass
Fentanyl Screen
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Independent Lab Report
Lab Verified3rd Party
Pass
Heavy Metals
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Heavy Metals (ICP-MS)Pass
Independent Lab Report
Lab Verified3rd Party
Pass
Microbial Screen
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Microbial screen (PCR)No Growth
Independent Lab Report
Lab Verified3rd Party
Pass
Endotoxin
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Endotoxin (USP <85>)NMT 0.05 EU/mL
Independent Lab Report
Lab Verified3rd Party
99.73%
Purity
Passed full QC panel
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Purity (HPLC)99.73%
Net Peptide Content10.62mg
Identity (HPLC)Confirmed
Heavy Metals (ICP-MS)Pass
Microbial screen (PCR)No Growth
Endotoxin (USP <85>)NMT 0.05 EU/mL
Independent Lab Report
Lab Verified3rd Party
Pass
Identity
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Identity (HPLC)Confirmed
Independent Lab Report
Lab Verified3rd Party
10.62mg
Net Peptide Content
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Independent Lab Report
Lab Verified3rd Party
Pass
Fentanyl Screen
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Independent Lab Report
Lab Verified3rd Party
Pass
Heavy Metals
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Heavy Metals (ICP-MS)Pass
Independent Lab Report
Lab Verified3rd Party
Pass
Microbial Screen
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Microbial screen (PCR)No Growth
Independent Lab Report
Lab Verified3rd Party
Pass
Endotoxin
Lot #CERG-10MG-CD-482
TestedNov 12, 2026
Full QC Panel
Endotoxin (USP <85>)NMT 0.05 EU/mL
Independent Lab Report

Cagrilintide Specifications

Structured specifications and handling data

Molecular profile

Technical specifications

Type:Synthetic Peptide (Amylin Analog)
CAS Number:1415456-99-3
Molecular Weight:4409 g/mol
Amino Acids:37
Sequence:Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 (cyclic Cys2-Cys7 disulfide; N-terminal gamma-Glu spacer carrying a C20 diacid)
Formula:C194H312N54O59S2
PubChem Database
Storage requirements

Stability and handling

Lyophilized
Cold Storage
Light Sensitive
Storage TemperatureStore in a cool, dry place away from light; refrigerate at 2–8°C (36–46°F)
ReconstitutionSterile water or bacteriostatic water recommended
StabilityStable when stored properly; avoid repeated freeze-thaw cycles

Frequently researched together

Compounds commonly studied alongside this one.

Cagrilintide research overview

Amylin receptors are not single proteins. They are built from the calcitonin receptor paired with one of the receptor activity-modifying proteins, and which RAMP is present changes what the receptor responds to. Cagrilintide was profiled against that whole family and turned out to be non-selective: it activates the amylin receptors and the calcitonin receptor alone, which separates it from amylin-selective analogs like pramlintide. The comparison across 25 binding, activation and receptor-regulation endpoints is the clearest published account of what the molecule actually does at the receptor.

The other half of the design is exposure. A fatty-acid chain attached through a glutamate spacer binds albumin, and measured half-life in a phase 1b trial ran 159 to 195 hours with time to peak concentration between 24 and 72 hours. Native amylin clears far too fast for that kind of experiment, so this is what makes sustained amylin-receptor activation a question a study can ask at all.

The pathway sits alongside incretin signaling rather than inside it, which is why much of the published work co-administers cagrilintide with GLP-1S. In the phase 1b combination trial, exposure was proportional to cagrilintide amount and did not affect GLP-1S exposure or elimination, so the two can be varied independently. Reported adverse events in these trials were predominantly gastrointestinal, and nausea rates in the phase 2 monotherapy trial ran 20% to 47% across amounts against 18% on placebo.

Amylin Receptor Activation

Profiled across 25 endpoints as a non-selective agonist of calcitonin family receptors, including AMY receptors and the calcitonin receptor.

Albumin Binding Kinetics

Trial pharmacokinetics reported a half-life of 159 to 195 hours, attributed to the lipid chain binding albumin.

Satiety Pathway Research

Amylin signaling has been studied in the area postrema and related brainstem circuits in animal models.

Incretin Co-Administration

Trials measured whether amylin and GLP-1 analog exposures interact when given together, and found they did not.

Cagrilintide Research Evidence

Published studies and concise summaries for research review.

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Lau DCW et al.

AI-generated summary of this research paper below.

The dose-finding trial for the investigational drug product, run at 57 sites in ten countries. 706 participants received once-weekly subcutaneous cagrilintide at 0.3 to 4.5 mg, 99 received liraglutide 3.0 mg and 101 received placebo over 26 weeks. Mean body-weight reductions were 6.0% to 10.8% across the cagrilintide amounts against 3.0% on placebo, and the 4.5 mg group separated from liraglutide at 10.8% versus 9.0%. Gastrointestinal events were the most common adverse events, reported by 41% to 63% of cagrilintide participants against 32% on placebo, with nausea at 20% to 47% against 18%. Permanent discontinuation was 10% overall, mostly for adverse events. The trial is the reference for the dose-response shape and for the tolerability profile that comes with it.
Research overview
Total Papers
60+
Year Range
2021+
Research status
Active
Peer-reviewed studies available
Research FAQ

Cagrilintide FAQs

Concise answers about laboratory context, handling, and documentation for this compound.

Laboratory compliance notice

All compounds sold by Validated Peptides are intended for in-vitro laboratory research only.

These materials are not approved by the FDA for human or animal use and are not intended for diagnostic, therapeutic, or clinical applications.

Purchasers are responsible for compliant handling, storage, and use within an appropriate laboratory environment.

Research Use Only
Not for Human Use
21+ Required